In response to a mass resignation of trainee physicians that has led to significant medical disruptions, the Korean government said it would spend 200 billion won ($150.1 million) per month into the healthcare system to maintain emergency and patient care.The Ministry of Health and Welfare on Thursd
In a significant milestone marking the ten-year collaboration between SK bioscience and Sanofi, a global leader in healthcare, the two companies have embarked on an ambitious expansion of the L HOUSE, SK bioscience’s vaccine manufacturing plant in Andong, North Gyeongsang Province.This expansion aim
Curocell, a Kosdaq-listed biotech company, said it received the topline data from its phase 2 clinical trial for its CAR-T (chimeric antigen receptor-T) therapy, Anbal-cel, to treat diffuse large B-cell lymphoma (DLBCL).The study is Korea's first clinical trial of a CAR-T therapy, involving 79 adult
Seoul National University Bundang Hospital (SNUBH) has spearheaded the launch of a network aimed at timely treatment of severe and emergency cardiocerebrovascular diseases, such as stroke and myocardial infarction, within Gyeonggi Province.This initiative, part of the Ministry of Health and Welfare'
Bridge Biotherapeutics has reported a significant downturn in its financial performance for the year 2023.The company's annual revenue plummeted to 100 million won ($74,878), marking a drastic 96.7 percent decrease compared to the previous year.This downturn is attributed to the absence of additiona
In a recent statement titled "Weight Management and CGM," the Korean Society for the Study of Obesity (KSSO) has voiced concerns over the unverified use of continuous glucose monitoring (CGM) devices for weight loss in individuals without diabetes.Such concerns come amid companies like Dr.Diary intr
The Korean medical device sector showcased its latest technologies and research achievements at the European Congress of Radiology 2024 (ECR 2024), held from Feb. 28 to last Suday in Vienna, Austria. ECR is recognized as one of the world's largest conferences in the field of radiology, alongside the
Binex, a Kosdaq-listed biopharmaceutical CDMO, has been subjected to a two-month suspension of sales operations for Bimo 5mg (ingredient: minoxidil), a hair loss treatment, for failing to submit necessary documents for the 2023 drug equivalence reevaluation.The product in question will not be availa
The Korean medical community is facing an unprecedented crisis as tensions escalate between the government and healthcare professionals over the proposed increase in medical school admissions by 2,000 in 2025.The dispute has broadened from trainee doctors to encompass the entire medical sector, with
i-SENS, a Kosdaq-listed biotech company, said it received product approval for CareSens Air, its continuous glucose monitoring (CGM) device, from the European Conformité Européenne (CE) Medical Device Regulation (MDR) last Thursday.The CareSens Air CGM system offers a non-invasive solution for diabe
Samjin Pharmaceutical announced a strategic investment of 1 billion won ($751,371) in Neurophet, a company specializing in AI solutions for brain disorder imaging, to fight dementia and stroke.Under the accord, the two companies seek to leverage Samjin’s extensive research resources, infrastructure,
Hugel said it received approval from the U.S. FDA for its botulinum toxin product, Letybo, in 50-unit and 100-unit dosages.This FDA approval marks a significant development for Hugel, following its third attempt to gain approval for Letybo.The company's journey to this point involved addressing feed
Celltrion said it reported consolidated sales of 2.1 trillion won ($1.5 billion) and operating income of 651 billion won in 2023, down 4.71 percent and up 0.66 percent, respectively, from the previous year.The company also posted a net profit of 539.2 billion won, down 0.53 percent, and an operating
Despite the government's ultimatum for disciplinary actions ending on Thursday, thousands of Korean medical residents have yet to return to work. As of Tuesday, a total of 9,267 residents from 100 training hospitals were ordered to return, with 5,976 confirmed to have not complied with the order.Vic
CHA Biotech said it had achieved its highest-ever annual revenue, posting a consolidated revenue of 954 billion won ($798 million) for the year 2023, up 13 percent from the previous year, thanks to strong business performance overseas.Despite the global economic slowdown, CHA Biotech attributed its
Kolon Life Science said it has decided to appeal to the Supreme Court against the revocation of the manufacturing and sales license for its knee osteoarthritis cell and gene therapy, Invossa-K Inj.This move comes after the company faced defeats in both the district and appellate courts.Most recently
Severance Hospital said that Professor Kuh Sung-uk at the Department of Neurosurgery, who also teaches at Yonsei University's College of Medicine, was honored with the grand prize at the 8th Medical Device Industry Awards Ceremony.Professor Kuh also serves as head of external relations at Severance
Celltrion said it has commenced the first shipment of Zymfentra, the world’s first subcutaneous form of infliximab, to the U.S. targeting autoimmune diseases. The company announced that the initial shipment batch was airlifted today to Atlanta, U.S., with plans to complete three shipment phases by e
In the rapidly evolving landscape of healthcare, digital therapeutics (DTx) have emerged as a groundbreaking third generation of treatment, drawing global attention as a promising sector. These software-based interventions, designed to treat diseases and enhance health much like traditional pharmace
Kakao Healthcare said over 50 health regulatory officials, including those from the Ministry of Food and Drug Safety, the WHO, and the U.S. FDA, visited its headquarters on Monday in light of the AI Regulatory and International Symposium 2024 (AIRIS 2024).The event is ongoing at the Shilla Seoul Hot